KIMBERLY MAHOWALD: Open Payments
NPI 1689195646 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 4 payments from 2 companies in 2025. Trend: 2023 $104 · 2024 $112 · 2025 $190
Food & beverage: $190
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $143 |
| ABBVIE INC. | 3 | $47 |
Products named: Yeztugo, IMBRUVICA, EPKINLY.
Industry payments across CO — which companies pay providers there.
